Skip to main content
. 2024 Apr 19;10(2):e003851. doi: 10.1136/rmdopen-2023-003851

Figure 1.

Figure 1

Classification of patients with seropositive RA and non-RA in the Stop Arthritis Very Early cohort according to the established 2010 ACR/EULAR classification criteria and refined criteria. Application of the refined serological scoring system improved specificity significantly (79% vs 47.4% misclassified patients with non-RA, p<0.0001), whereas sensitivity was not affected (97.3% correctly classified patients with RA). *χ2 for proportions (MedCalc Software, Ostend, Belgium). RA, rheumatoid arthritis.